Charles River Laboratories International Inc (CRL)
195.77
+1.58
(+0.81%)
USD |
NYSE |
Nov 22, 16:00
195.80
+0.03
(+0.02%)
After-Hours: 20:00
Charles River Laboratories International Price: 195.77 for Nov. 22, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Nov 22, 2024 | 194.12 | 198.18 | 193.26 | 195.77 | 575545.0 |
Nov 21, 2024 | 189.20 | 194.88 | 186.62 | 194.19 | 502262.0 |
Nov 20, 2024 | 186.54 | 188.32 | 183.55 | 187.90 | 648096.0 |
Nov 19, 2024 | 185.84 | 188.38 | 183.91 | 186.10 | 714433.0 |
Nov 18, 2024 | 185.28 | 187.93 | 183.58 | 187.50 | 779956.0 |
Nov 15, 2024 | 195.42 | 196.00 | 183.35 | 187.74 | 1.499M |
Nov 14, 2024 | 206.50 | 208.10 | 195.96 | 196.90 | 974396.0 |
Nov 13, 2024 | 216.12 | 217.75 | 205.55 | 206.54 | 981957.0 |
Nov 12, 2024 | 220.00 | 221.60 | 213.35 | 215.94 | 756423.0 |
Nov 11, 2024 | 217.44 | 222.10 | 217.00 | 220.69 | 774726.0 |
Nov 08, 2024 | 210.29 | 216.14 | 208.52 | 215.39 | 625749.0 |
Nov 07, 2024 | 215.75 | 217.60 | 209.97 | 210.29 | 852790.0 |
Nov 06, 2024 | 228.99 | 230.02 | 208.55 | 214.20 | 2.285M |
Nov 05, 2024 | 180.89 | 189.18 | 180.50 | 188.68 | 997754.0 |
Nov 04, 2024 | 179.93 | 185.86 | 179.93 | 182.48 | 519209.0 |
Nov 01, 2024 | 180.40 | 184.04 | 179.46 | 180.96 | 830357.0 |
Oct 31, 2024 | 178.91 | 181.23 | 176.48 | 178.58 | 1.032M |
Oct 30, 2024 | 181.19 | 186.37 | 180.24 | 181.39 | 792289.0 |
Oct 29, 2024 | 186.00 | 186.46 | 182.22 | 184.00 | 692472.0 |
Oct 28, 2024 | 185.21 | 188.00 | 184.26 | 186.52 | 506517.0 |
Oct 25, 2024 | 184.15 | 184.55 | 181.53 | 182.12 | 501310.0 |
Oct 24, 2024 | 185.00 | 186.32 | 180.22 | 182.73 | 1.053M |
Oct 23, 2024 | 185.54 | 188.06 | 184.16 | 186.63 | 610694.0 |
Oct 22, 2024 | 191.01 | 191.01 | 180.75 | 185.94 | 1.197M |
Oct 21, 2024 | 196.60 | 197.64 | 194.91 | 195.04 | 592577.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
98.90
Minimum
Mar 18 2020
458.30
Maximum
Sep 24 2021
241.84
Average
220.20
Median
Price Benchmarks
Boston Scientific Corp | 90.00 |
CVS Health Corp | 58.01 |
Arbutus Biopharma Corp | 3.51 |
FibroBiologics Inc | 2.60 |
Biomarin Pharmaceutical Inc | 64.26 |
Price Related Metrics
PE Ratio | 24.44 |
PS Ratio | 2.490 |
Price to Book Value | 2.647 |
Price to Free Cash Flow | 18.04 |
Earnings Yield | 4.09% |
Market Cap | 10.01B |
Operating PE Ratio | 19.15 |
Normalized PE Ratio | 24.44 |